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PKCεFatty acids (FAs) are known to impair insulin signaling in target cells. Accumulating evidences suggest that
one of the major sites of FAs adverse effect is insulin receptor (IR). However, the underlying mechanism is yet
unclear. An important clue was indicated in leptin receptor deﬁcient (db/db) diabetic mice where increased
circulatory FAs was coincided with phosphorylated PKCε and reduced IR expression. We report here that
central to this mechanism is the phosphorylation of PKCε by FAs. Kinase deadmutant of PKCε did not augment
FA induced IRβ downregulation indicating phosphorylation of PKCε is crucial for FA induced IRβ reduction.
Investigation with insulin target cells showed that kinase independent phosphorylation of PKCε by FA
occurred through palmitoylation. Mutation at cysteine 276 and 474 residues in PKCε suppressed this process
indicating participation of these two residues in palmitoylation. Phosphorylation of PKCε endowed it the
ability to migrate to the nuclear region of insulin target cells. It was intriguing to search about how
translocation of phosphorylated PKCε occurred without having canonical nuclear localization signal (NLS).
We found that F-actin recognized phospho-form of PKCε and chaperoned it to the nuclear region where it
interact with HMGA1 and Sp1, the transcription regulator of IR and HMGA1 gene respectively and impaired
HMGA1 function. This resulted in the attenuation of HMGA1 driven IR transcription that compromised insulin
signaling and sensitivity.ted at Visva-Bharati University,
91 3463 261176. A. Datta, tel.:
a), bhattacharyasa@gmail.com
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Interaction of insulin with its receptor tyrosine kinase triggers
intracellular cascade of kinases that leads to cellular uptake of glucose
in insulin target cells. Several authors have demonstrated that
downregulation of IR is accompanied by diminished insulin signaling
causing insulin resistance [1–4]. A few signiﬁcant information
relevant to this are enumerated below (a) IR knockout in mice liver
leads to the development of insulin resistance and type 2 diabetes [3],
(b) induction of endoplasmic reticulum stress abrogates IR expression
that causes insulin resistance [5], (c) number of IR per adipocyte
signiﬁcantly decreases in the obese patients [1], (d) this has been
further conﬁrmed with ﬁbroblasts, the precursor cells of adipocytes,
collected from insulin resistant patients showed both quantitative and
qualitative defects of IR [6], (e) defects in IR gene expression have
been detected in insulin resistant patients [7]. (f) HMGA1, architec-
tural transcription factor of IR gene, has been found to be deﬁcient indiabetic patients and this effected reduced IR expression [8]. Hence,
from all these reports it appears that reduction of IR is associated with
insulin signaling defect which produces insulin resistance and
diabetic in human being.
To search the cause for such reduction, many suggested lipid as the
major player. Reduced IR expression has been observed in mice with
abdominal obesity andhepatic steatosis [9]. Saturated longchain FAs are
shown to be associated with the defects of insulin signaling. Palmitate
decreased IR protein and mRNA expression in hepatocyte and skeletal
muscle cell lines that attenuates insulin signaling [4,10] and a
concentration dependent decline of IR occurs in insulin target cells
due to palmitate [11]. Lipid transfection to skeletal muscle cells and
adipocytes reduces IR expression that impairs insulin responsiveness
[12]. These information are consistent in implying that FA induced
reduction of IR is one of the causes to develop insulin resistance but how
lipid is related to IR downregulation in insulin target cells is still unclear.
A few reports indicated interplay of protein kinase Cε (PKCε) in
mediating the lipid induced IR damage. It has been shown that IR
expression is inversely correlated to PKCε in diabetic obese rats [13].
Moreover, lipid induced hepatic insulin resistance could be prevented
by knocking down of PKCε [14]. PKCε is implicated in the impairment
of HMGA1 that coincided with the reduced IR expression [15]. These
fragmented reports appear to be meaningful and there might be an
Table 1
Primers used in the present study.
Organism Primer Direction Sequence
Mice HMGA1 Forward 5′-CCGGCCCCATCTCACTCTGA-3′
Reverse 5′-GTGTGGGGTAGGTAACCAGT-3′
Rat HMGA1 Forward 5′-CAGGAAAAGGATGGGACTGA-3′
Reverse 5′-CAGAGGACTCCTGGGAGATG-3′
Mice IRβ Forward 5′-AATGGCAACATCACACACTACC-3′
Reverse 5′-CAGCCCTTTGAGACA-ATAATCC-3′
Rat IRβ Forward 5′-GGATGGTCAGTGTGTGGAGA-3′
Reverse 5′-TCGTGAGGTTGTGCTTGTTC-3′
Mice GAPDH Forward 5′-CCACCCATGGCAAATTCCATGGCA-3′
Reverse 5′-TCTAGACGGCAGGTCAGGTCCACC-3′
Rat GAPDH Forward 5′-GCCATCAACGACCCCTTC-3′;
Reverse 5′-AGCCCCAGCCTTCTCCA-3′
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we report that lipid induced phosphorylation of PKCε occurs due to
palmitoylation. Phosphorylated PKCε is transported to the nuclear
region by F-actin where it impaired HMGA1 resulting reduced IR
expression that signiﬁcantly decreases insulin sensitivity in target
cells.
2. Materials and methods
2.1. Materials
All tissue culture materials were obtained from Gibco-BRL, Life
Technologies Inc., Gaithersburg, USA. Anti-PKCε (anti-rabbit), anti-
pPKCε (Ser-729, anti-rabbit), anti-HMGA1 (anti-rabbit), anti-pIRβ
(Tyr 1150/1151, anti-mouse), anti-IRβ (anti-rabbit), anti-p-c-Jun
(Ser-63/73, anti-rabbit) and anti-p-c-Fos (Thr-232, anti-rabbit)
antibodies were purchased from Santa Cruz Biotechnology Inc.,
California, USA. Anti-F-actin (anti-mouse) and anti-pSp1 (Thr-453,
anti-rabbit) antibodies were from Abcam Inc., Cambridge, USA. All
ﬂuorescent (goat anti-rabbit ﬂuorescence iso-thiocyanate (FITC);
rabbit anti-mouse rhodamine) and alkaline phosphatase conjugated
secondary antibodies were purchased from Sigma Chemical Co., St.
Louis MO, USA. [γ-32p]-ATP (Speciﬁc activity: 3800 Ci/mmol) was
procured from BRIT, India. [14C]-Palmitic acid (Speciﬁc activity: 52 Ci/
mmol) and [3H]-2-deoxyglucose (Speciﬁc activity: 12.0 Ci/mmol)
were purchased from GE Healthcare Biosciences Ltd., Kowloon, Hong
Kong. All fatty acids, cerulenin, triacsin C and cytochalasin B were
from Sigma Chemical Co., St. Louis MO, USA. PKCε translocation
inhibitor peptide EAVSLKPT (εV1) was purchased from Calbiochem,
Darmstadt, Germany. All the restriction enzymes and Gaussia
Luciferase assay kit were from New England Biolabs (UK) Ltd.
Hertfordshire, England, UK. Serum glucose level was measured by
using glucose oxidase method and serum FFA levels were measured
by acyl-CoA synthase and acyl-CoA oxidase methods (Roche Diag-
nostics, Indianapolis, USA). The other chemicals and reagents used
were purchased from Sigma Chemical Co., St. Louis MO, USA.
2.2. Mice
Diabetic male db/db mice (BKS.Cg-m +/+ Leprdb/J, stock #
000642) and their age matched non-diabetic mice (C57BLKS/6J)
obtained from Jackson's laboratory were housed in group of 5
individuals/cage under 12 h light/dark cycle at 23±2 °C (humidity
55±5%) with ad libitum access to food and water. All experiments
were performed following the guidelines prescribed by the Animal
Ethics Committee.
2.3. FFA treatments
FFAs were conjugated with FFA-free bovine serum albumin
following the method described by Chavez et al. [16]. Brieﬂy, FFAs
were dissolved in ethanol and diluted 1:100 in 1% FBS-DMEM
containing 5% (w/v) bovine serum albumin.
2.4. Cell culture and treatments
The rat L6 skeletal muscle, human HepG2 and mouse 3T3-L1 cell
lines were kind gifts from Dr. Partha P. Banerjee, Georgetown
University Medical Center, Washington, DC, USA. Cells were cultured
in a similar manner as described by us previously [15]. Brieﬂy, L6
skeletal muscle cells were cultured in DMEM medium supplemented
with 10% fetal calf serum, 25 mM glucose, 1% penicillin-streptomycin
(Invitrogen) in a humidiﬁed 95% O2/5% CO2 atmosphere at 37 °C. Cells
attaining 60–70% conﬂuence were differentiated in DMEM containing
2% fetal bovine serum and 1% pen-strep for 4–6 days prior to all
experiments. HepG2 and 3T3-L1 adipocytes were cultured in a similarmanner as described previously [17]. Cells were incubated for 6 hwith
0.3 mM concentration of different fatty acids conjugated with 5% BSA
with or without inhibitors mentioned at speciﬁc places. PKCε siRNA,
wild type and mutated pCMV-PKCε vectors were transfected to L6
myotubes (2×105 cell/well) by using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) following manufacturer's protocol. After 48 h of
transfection, cells were washed with DMEM. Transfected cells were
then used for different experiments. On termination of incubations,
cells were washed twice with ice-cold PBS and harvested with trypsin
(0.25%)–EDTA (0.5 mM). Cell pellets were resuspended in lysis buffer
(1% NP-40, 20 mM HEPES (pH 7.4), 2 mM EDTA, 100 mM NaF, 10 mM
sodium pyrophosphate, 1 mM sodium orthovanadate, 1 μg/ml leu-
peptin, 1 μg/ml aprotinin, 1 μg/ml pepstatin and 1 mM PMSF),
sonicated on ice and lysates were centrifuged for 10 min at 10,000 g
and protein concentrations of supernatant were determined by the
method of Lowry et al. [18].
2.5. Electrophoresis and immunoblotting
Sixty micrograms of protein from the lysates of control and treated
cells were resolved on 10% or 12.5% SDS-PAGE and transferred to
PVDF membranes (Millipore, Bedford, MA) with the help of Semi-Dry
trans blot Apparatus (Bio-Rad Trans-Blot® SD-Cell). The membranes
were ﬁrst incubated with respective primary antibodies at 1:1000
dilutions followed by incubation with either alkaline phosphatase
conjugated goat anti-rabbit or rabbit anti-mouse secondary anti-
bodies at same dilutions using SNAP i.d.TM Apparatus (Millipore,
Bedford, MA). The protein bands were detected by using 5-bromro 4-
chloro 3-indolyl phosphate/nitroblue tetrazolium (BCIP/NBT).
2.6. Reverse transcription-PCR (RT-PCR) and real time quantitative PCR
(qPCR)
Total RNA was extracted from different incubations using TRI
Reagent (Sigma-Aldrich) according to the manufacturer's instruc-
tions. RT-PCR was performed using Revert AidΤΜ ﬁrst strand cDNA
synthesis kit (Fermentas Life Sciences, Hanover, MD). Gene expres-
sion was quantiﬁed using Real time PCR (Applied Biosystems Inc. CA).
PCR was performed using gene-speciﬁc primers with the following
reaction conditions: initial activation step at 95 °C for 15 min, then 40
cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 30 s and
ﬁnal extension at 72 °C for 30 s. Gapdh was simultaneously ampliﬁed
in separate reactions. The Ct value was corrected using corresponding
Gapdh controls. Primer sequences used were as shown in Table 1.
2.7. [3H] 2-deoxyglucose uptake
[3H] 2-deoxyglucose (2-DOG) uptake in L6myocyteswas performed
according to the previous description [19]. L6 myocytes were serum
starved overnight in Kreb's Ringer Phosphate (KRP) buffer (12.5 mM
HEPES, pH 7.4, 120 mM NaCl, 6 mM KCl, 1.2 mM MgSO4, 1 mM CaCl2,
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serum albumin. Cells were incubated in absence or presence of
palmitate (0.30 mM) for 4 h followed by 30min incubation with
porcine insulin (100 nM). After 25 min, [3H] 2-DOG (0.4 nmol/ml) was
added to each of the incubations 5 min before the termination of
experiment. Cells were washed thrice with ice-cold KRP buffer in the
presence of 0.3 mM phloretin to correct the glucose uptake data from
simple diffusion and non-speciﬁc trapping of radioactivity. Cells were
harvestedwith trypsin (0.25%)–EDTA (0.5 mM), solubilizedwith1%NP-
40 and 2-DOG uptake was measured in a Liquid Scintillation counter
(Perkin Elmer, Tri-Carb 2800TR).
2.8. Metabolic labeling
L6 skeletal muscle cells were incubated with 0.8 mCi/ml [14C]-
palmitic acid for varied time periods at 37 °C and on termination of
incubations cells werewashedwith PBS to remove the free label. PKCε
was immunoprecipitated and subjected to electrophoresis followed
by ﬂuorography. We used CSS-palm palmitoylation algorithm [20] to
predict the cysteine residues within the entire coding sequence of
PKCε as probable site of palmitoylation and it was set to the highest
cutoff in CSS-palm algorithms.
2.9. Co-immunoprecipitation
Cells were incubated without or with palmitate or palmitate plus
εV1. On termination of incubation, nuclear fractions were extracted
[19] and used for immunoprecipitation. Brieﬂy, 200 μg of nuclear
protein was incubated overnight at 4 °C with either 2 μg of anti-F-
actin or anti-HMGA1 antibody. Around 50 μl of Protein A Sepharose
was then added to each tube and incubated at 4 °C for 2 h followed by
centrifugation at 10,000g. Immunocomplexed F-actin or HMGA1 was
resuspended in 500 μl of 0.1% CHAPS in PBS andwashed thoroughly in
PBS. Immunoprecipitates were boiled in 5× SDS sample buffer and
resolved in 10% SDS-PAGE followed by immunoblotting with either
anti-PKCε or anti-pPKCε antibody.
2.10. Confocal microscopy
Confocal microscopy was performed by following the description
reported previously by us [21]. Brieﬂy, control and treated L6 skeletal
muscle cells were incubated with both anti-rabbit pPKCε and anti-
mouse F-actin antibodies for 2 h followed by double staining with
FITC-conjugated goat anti-rabbit and Rhodamine conjugated rabbit
anti-mouse antibodies for 1 h. Coverslips were then mounted on glass
slides and examined under laser scanning confocal microscope (Leica
Corp., Rockleigh, NJ).
2.11. Immunoafﬁnity chromatography
To prepare pPKCε rich fraction, L6 skeletal muscle cells were
incubated for 6 h with palmitate. On termination of incubation, cells
were lysed and supernatant was isolated. The supernatant was passed
through Microcon YM-50 followed by YM-100 ﬁlter devices to
remove the protein below and above of 50 kDa and 100 kDa
respectively. Filtrate from YM-100 was used for immunoafﬁnity
chromatography where cyanogen bromide (CNBr) activated Sephar-
ose 4B beads were conjugated with the anti-pPKCε antibody by
following the procedure previously described by us [19]. Puriﬁed
pPKCε was used for Surface plasmon resonance analysis.
2.12. Surface Plasmon Resonance (BIAcore) Study
To observe the interaction between pPKCε and HMGA1, Surface
plasmon resonance experiments were performed on a BIAcore™ 3000
instrument (BIAcore, Inc., Uppsala, Sweden) using NTA sensor chipfollowing manufacturer's instructions. Brieﬂy the NTA sensor chip
was equilibrated with running buffer containing 10 mM HEPES (pH
7.5), 150 mM NaCl, 0.005% Surfactant P20, 50 mM EDTA followed by
priming the chipwith 0.1 MNiCl2 and again equilibratedwith running
buffer, then pure His-HMGA1 protein ﬂowed over the Ni2+ coated
NTA sensor chip surface at a ﬂow rate of 5 μl/min. The ﬁnal amount of
His-HMGA1 protein covalently immobilized on the surface was
600RU. To observe the pattern of HMGA1-pPKCε binding, pPKCε
from 50 to 400 nM concentrations was run over the HMGA1
immobilized Ni2+ primed NTA chip at a ﬂow rate of 5 μl/min for
10 min. Binding between these two proteins was monitored in real
time via the changes in refractive indexwhich was proportional to the
changes in mass concentration at the sensor chip surface and plotted
as Resonance Unit (RU) versus time.
The sensorgram was corrected by subtracting the initial level of
SPR signal before injection of the pPKCε. Binding kinetics was
analyzed for one-to-one Langmuir binding model provided with BIA
evaluation software.
2.13. Immunocomplex kinase assays
L6 skeletal muscle cells were incubated with palmitate in presence
of [γ32p]-ATP and on termination of incubation, cytosolic fractions
were isolated and subjected to Microcon ﬁlter devices (Millipore,
Bedford, MA) through YM-50 and then YM-100, ﬁltrate from YM-100
was collected and subjected to immunoprecipitation with anti-pPKCε
antibody. Immunoprecipitated 32pPKCε was used for immune-
complex kinase assays under the following reaction conditions in a
total volume of 30 μl: 10 mM MgCl2, 10 μg HMGA1 or Sp1 and 10 μCi
of [γ-32P]ATP (80 μM) at 25 °C. The kinase reaction was stopped by 1×
SDS sample buffer and resolved on 10% SDS-PAGE, transferred to
PVDF membrane, followed by autoradiography. Radioactive spot
corresponding to HMGA1 or Sp1 was cut from the PVDF membrane
and radioactivity was measured in a liquid scintillation counter.
2.14. Chromatin Immunoprecipitation (ChIP) assay
ChIP assaywas performed using a ChIP assay kit (Upstate, Temecula,
CA) according to the manufacturer's protocol using anti-HMGA1
antibody. The primers (forward: 5′-AACCACCTCGAGTCACCAAAA-3′
and reverse: 5′-AGAGAGAGGGAAAGCTTGCAG-3′)were used to amplify
the immunoprecipitated insulin receptor promoter sequence. The PCR
products were resolved on ethidium bromide stained 1.5% agarose gel
and image was captured by Bio-Rad Gel documentation system.
2.15. Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from control, palmitate, and
palmitate plus εV1 treated cells as described previously [22]. EMSA
was performed by using nuclear extracts prepared from different
incubations using oligonucleotide probes speciﬁc for Sp1 binding site
(forward: 5′-ATTTGCATGGCCCCGCCCCCTGAGT-3′, reverse: 5′-ACT-
CAGGGGGCGGGGCCATGCAAAT-3′) within the HMGA1 promoter. The
probes were end labeled with [γ32P]-ATP with T4 polynucleotide
kinase and incubated with 10 μg of nuclear extracts in 20 μl of binding
reaction for 45 min on ice. For supershift assay, 2 μg of anti-Sp1
antibody was added to the nuclear extract and the reaction mixture
was resolved on 5% polyacrylamide gel and visualized by Phosphor-
imager (GE Healthcare, USA).
2.16. Site directed mutagenesis
A pCMV6-PKCε construct containing 5537 bp of human protein
kinase C, epsilon gene (Genbank/EMBL NM_005400.2) was purchased
from OriGene Technologies, Inc, Rockville, MD, USA. This vector
construct was used as template for the generation of mutant
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system (Stratagene, CA, USA). For mutated PKCε plasmid construc-
tion, sense oligos included oligohPKCεS729A (5′-GAGGAATT-
CAAAGGTTTCGCCTACTTTGGTGAAGACC-3′), oligohPKCεΔ729 (5′-
GGAGGAATTCAAAGGTTTCTACTTTGGTGAAGACCTGA-3′) oligohPK-
CεC13A (5′-GGCCTTCTTAAGATCAAAATCGCCGAGGCCGTGAGCT-3′),
oligohPKCεC276A (5′-AGGGTTTGCAGTGTAAAGTCGCCAAA-
ATGAATGTTCACCGTC-3′), oligohPKCεC474A (5′-ACCTTACCCAACTC-
TACGCCTGCTTCCAGACCAAGG-3′), oligohPKCεC652A (5′-
CAAGCGCCTGGGCGCTGTGGCATCGCAG-3′).
2.17. Plasmid construct, transfection and reporter assay
IRP-GLucplasmidwasgenerated by following a previouslydescribed
method with some modiﬁcations [23]. Brieﬂy, the insulin receptor
promoter sequence was ampliﬁed by PCR taking phINSRP-1 as a
template with forward (5′-GGGGGAATTCGGCCATTGCACTCCA-3′) and
reverse (5′-AATTGGATCCTGCGGGAGCGCGGGG-3′) primers. The PCR
products were digested with EcoRI/BamHI and cloned into the pGLuc
vector yielding pIRP-GLuc. The sequence of cloned promoter regionwas
conﬁrmed by sequencing. Cells were transfected for 72 h with pIRP-
GLuc plasmid (0.25 mg/well) using LipofectamineTM 2000 and lucifer-
ase activity was measured from the media of incubated cells.
2.18. Statistical analysis
All data were derived from at least three independent experiments
and analyzed by one-way analysis of variance (ANOVA); where the
F value indicated signiﬁcance, means were compared by a post hoc
multiple range test. All values were means±SEM.
3. Results
3.1. Correlation between fatty acid, PKCε phosphorylation and
downregulation of IR
To study the lipid's association in IR degradation, we selected
genetically modiﬁed leptin receptor deﬁcient db/db mice which are
extremely insulin resistant and obese in comparison to their control
littermates (Fig. 1A, B). There was a drastic reduction of IRβ protein
and gene expression in insulin target tissues of db/db mice as
compared to their control (Fig. 1C). This was coincided with
signiﬁcant increase in circulatory FFA level, where palmitate and
myristate were prevalent (Fig. 1D, E). Interestingly, there was a
signiﬁcant amount of phosphorylated PKCε (pPKCε) in insulin target
tissues of db/db mice as compared to their control, while its non-
phospho form did not show such difference (Fig. 1F). Nutritionally
induced high fat diet (HFD) rats also exhibited similar trend (Fig.
S1A). These results from in vivo mice model provided two valuable
information - (i) two long chain FAs are important in producing
damage and (ii) association of phospho-PKCε with IRβ reduction.
These ﬁndings prompted us to examine the effect of saturated and
unsaturated FAs on the reduction of IRβ in L6 myotubes. Maximum
reduction occurred with two long chain saturated fatty acids,
palmitate and myristate (Fig. 2A). These FAs greatly increased PKCε
phosphorylation with concurrent reduction of IRβ expression in
insulin target cells (Fig. 2B, C). This emphasizes the involvement of
pPKCε with IRβ downregulation. It could be seen from Fig. 2D that an
unsaturated fatty acid, oleate, also phosphorylated PKCε although
with the same concentration it showed no effect on IR expression
(Fig. 2A). To observe acute and chronic effects of FFA on insulin
resistance, we incubated L6myotubeswith different concentrations of
palmitate (0.25 to 1.0 mM) at 4 h, 8 h and 16 h time periods in the
presence of insulin. Palmitate inhibited insulin stimulated [3H] 2-
deoxyglucose (2-DOG) uptake in a dose dependent manner, howevereven lower doses of it i.e., 0.25 and 0.5 mM showed greater inhibition
due to chronic treatment for 16 h (Fig. 2E).
It was evident that higher concentration of palmitate may cause
cellular apoptosis [24,25], however, varied concentrations of palmi-
tate conjugated with BSA demonstrated that exposure till 0.4 mM had
no effect on caspase 3 activity, a marker of apoptosis, in L6 myotube
whereas 0.5 mM showed a marginal effect (Fig. 2F). We therefore
selected 0.3 mM concentration of palmitate conjugated BSA in our
experiments as it will have no apoptotic effect during incubation
periods (Fig. S1B).
3.2. IRβ degradation by FAs is executed through pPKCε
We, therefore, felt it to be necessary to study whether pPKCε is
mediating palmitate effect on downregulation of IRβ expression. To
investigate this, PKCε was mutated or deleted at serine 729
phosphorylation site and transfected to L6 myotubes. Incubation of
these transfected cells with palmitate did not increased pPKCε or
inhibited IRβ expression (Fig. 3A). Forced expression of PKCε in L6
myotubes followed by palmitate incubation markedly reduced IRβ
expression, even less than palmitate lone effect while in PKCε
knockout (KO) cells palmitate failed to reduce IRβ expression. These
results strongly indicate that population of pPKCε could be related to
the magnitude of IRβ reduction (Fig. 3B). We then examined
palmitate effect on downstream insulin signaling molecules and
found that palmitate also inhibited insulin stimulated activation of
IRS1 and Akt along with the IRβ (Fig. 3C). Taken together, palmitate
induced phosphorylation of PKCε appears to be a key step in FA
induced IRβ degradation which resulted impairment of downstream
signaling molecules.
3.3. Lipid induced phosphorylation of PKCε is due to palmitoylation
Cellular phosphorylation of PKC is always dependent on PDK1; in
contrast, FA induced phosphorylation appears to be not through PDK1
[15,26]. Myristoylated PKCε has been shown to be constitutively
phosphorylated in PDK1 knock out cells [26]. Here we show that
radiolabeled palmitate incubation of L6 myotubes effected palmitoy-
lation of PKCε (Fig. 4A). Addition of HCl, NaOH or hydroxylamine
inhibited the palmitoylation indicating presence of thioester bond
between radiolabeled palmitate and PKCε (Fig. 4B). That palmitoyla-
tion of PKCε leads to its phosphorylation was evident from the effect
of palmitoylation inhibitors, triacsin C and cerulenin, which sup-
pressed palmitoylation and subsequently inhibited phosphorylation
of PKCε (Fig. 4C, S1C). To search the possible site(s) of palmitoylation
on PKCε, we mutated four probable cysteine residues in PKCε i.e., 13,
276, 474 and 652 (Fig. 4D) and transfected them to L6 myotubes
followed by incubation with [14C]-palmitate. Determination of
palmitoylated PKCε through immunoprecipitation followed by ﬂuo-
rography and immunoblot for pPKCε suggests that mutation at 276
and 474 cysteine residues completely abolished both palmitoylation
and phosphorylation whereas mutation at 13 and 652 had no effect
(Fig. 4E). Hence, 276 and 474 cysteine residues are the sites for
palmitoylation which leads to PKCε phosphorylation.
3.4. pPKCε translocation to nuclear region is chaperoned by F-actin
Previously, we have observed that phosphorylation of PKCε has
endowed it the ability for nuclear translocation [15] but could not
understand how it occurs in the absence of canonical nuclear
localization signal (NLS). From some earlier information it occurred
that F-actin, which has 13 NLS, may be a transporter of pPKCε since
phorbol ester induced activated PKCε remains bound to F-actin
[27,28] and they could be detected as co-localized in the nuclear
region [29]. Coimmunoprecipitation study indicates that in palmi-
tate and myristate incubated L6 myotubes, F-actin formed a
Fig. 1. Interrelationship between fatty acids, pPKCε and IR in db/dbmice. (A) Serum was collected from db/dbmice and its control littermate (Con) followed by estimation of glucose level. (B) Skeletal muscle cells isolated from control and
db/db mice were incubated in vitrowith [3H]-2DOG followed by the determination of its uptake in a liquid scintillation counter. (C) Skeletal muscle, liver and fat tissues from these mice were subjected to immunoblot analysis using anti-IRβ
antibody (upper panel) or qPCR (lower panel) to determine the IRβ protein and mRNA level, β actin and gapdhwere used as internal control. (D, E) Serum FFA level was measured by acyl-CoA synthase and acyl-CoA oxidase methods where
palmitate and myristate were found to be the major FAs in the serum of db/dbmice in comparison to control. (F) Immunoblot analysis of PKCε and pPKCε level in above tissues where β actin represent as loading control. Each experimental
data represented the mean value of six individual animals. All data represented are means±SEM of ﬁve individual experiments, *pb0.01 vs Con.
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Fig. 3. FA induced IRβ degradation mediated through pPKCε (A) Analysis of pPKCε, PKCε and IRβ levels in L6 myotubes untransfected (UT) or transfected with PKCε site-mutant
(S729A) or deletion-mutant (ΔS729) followed by incubation without or with palmitate. (B) Incubation of pCMV-PKCε or PKCε siRNA transfected L6 myotubes with palmitate followed
by immunoblotting with indicated antibodies. (C) Incubation of L6 myotubes with insulin in absence or presence of palmitate (P) followed by IRβ, IRS1 and Akt immunoblotting.
Figures are representative of one of three independent experiments; β actin was used as loading control.
Fig. 4. PKCε acylation causes kinase independent autophosphorylation. (A) L6 myotubes were incubated for indicated time periods with radiolabeled [14C]-palmitate. PKCε was
immunoprecipitated and subjected to SDS-PAGE followed by ﬂuorography (FG) or immunoblotting (IB). (B) Immunoprecipitated PKCεwas incubated for 1 h at 30 °Cwith either Tris
buffer, or neutral 2 M hydroxylamine (HDX) or 2 N HCl or 2 N NaOH followed by SDS-PAGE and ﬂuorography (FG) or immunoblotting (IB). (C) L6 myotubes were incubated without
or with palmitate in the absence or presence of cerulenin or triacsin C. On termination of incubations cell lysates were immunoblotted with pPKCε or PKCε antibodies. (D)Wild type
PKCε vector was mutated at indicated positions to generate mutated forms where cysteine was replaced by alanine through site directed mutagenesis. (E) Wild type and mutated
vectors transfected L6myotubes were incubated with [14C]-palmitate. PKCε and pPKCεwas immunoprecipitated with respective antibodies followed by SDS-PAGE and ﬂuorography
(FG) to detect amount of radiolabeled palmitate incorporation to PKCε (upper panel) or immunoblot (IB) analysis to observe amount of PKCε phosphorylation (lower panel).
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This was also observed with 3T3-L1 adipocytes (Fig. S1D). F-actin
destabilizing agent, Cytochalasin B (cytoB) and PKCε translocation
inhibitor, εV1 blocked PKCε translocation to nuclear region
(Fig. 5B). Confocal microscopy study exhibited weak and diffusedFig. 2. Palmitate andmyristate are key players in lipid induced IRβ reduction. (A) L6 myotube
(B) L6 myotube, HepG2 and 3T3-L1 cells were incubated without or with palmitate (P) or m
(C) Total RNA extracted from these cells was subjected to RT-PCR to determine the IRβmRN
with two different fatty acids, palmitate and oleate (O) for 4 h. Cells without any treatment se
anti-pPKCε antibody, β-actin served as internal control. (E) Effect of varied doses of palmita
varied concentration of palmitate (0.25 to 1.0 mM) at different time periods (4 to 16 h) in th
lysed, centrifuged and radioactivity of the supernatant was counted in a liquid scintillation
response to varied concentrations of palmitate. *pb0.05 vs C. (E) All data are Mean±SEMstaining of pPKCε in the cytoplasm of control cells and a total
absence of it in the nuclear region, while in palmitate incubated
cells a considerable amount of pPKCε was detected in the nuclear
region and found to be colocalized with F-actin (Fig. 5C). These
results provided an additional support to the above contention thatincubated with different FAs, followed by immunoblot analysis with anti-IRβ antibody.
yristate (M) followed by immunoblot analysis with anti-pPKCε or anti-IRβ antibodies.
A level, gapdhwas used as internal control. (D) L6 skeletal muscle cells were incubated
rved as control. On termination of incubation, cells were lysed and immunoblotted with
te on [3H] 2-deoxyglucose (2-DOG) uptake by L6 myotubes. L6 cells were treated with
e absence (C) or presence of 100 nM of insulin. On termination of incubations cells were
counter. (F) Examination of cellular apoptosis as determined by caspase 3 activity in
of three individual experiments.
Fig. 5. Palmitate induced pPKCε nuclear translocation is mediated through F-actin. (A) Nuclear extract isolated from palmitate (P) or myristate (M) incubated L6 myotubes were
subjected to immunoprecipitation with anti-F-actin antibody followed by probing with pPKCε or PKCε antibodies. β actin was used as internal control. (B) L6 myotubes were
incubated without or with palmitate in the presence or absence of εV1 or Cytochalasin B (CytoB). On termination of incubations cytosolic (Cyt) and nuclear (Nu) fractions were
prepared and subjected to immunoblot analysis with pPKCε antibody, β actin was used as internal control. (C) L6 myotubes were incubated without (control) or with palmitate, on
termination of incubations, cells were ﬁxed and permeabilized. Permeabilized cells were coincubated with anti-rabbit pPKCε and anti-mouse F-actin antibodies for 4 h followed by
FITC and Rhodamine conjugated respective secondary antibodies for 2 h. DAPI was used to stain the nucleus. Figures are representative of one of three independent experiments.
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actin in palmitate incubated cells.
3.5. pPKCε entry into the nuclear region effected HMGA1 impairment
Biological relevance of pPKCε translocation to nuclear region of
insulin target cells was previously indicated by demonstrating its
association with HMGA1 [15]. HMGA1 is a transcriptional regulator of
IR gene [8,30,31]. Here we show that pPKCε form a complex with
HMGA1 in the nuclear extract of palmitate incubated cells which was
inhibited by cytochalasin B and εV1 (Fig. 6A). To assess the binding
afﬁnity between pPKCε and HMGA1, we used surface plasmon
resonance analysis (SPR, BIAcore). Pure His-HMGA1 was tethered to
a Ni2+-NTA sensor chip via their NH2 terminal His6 moieties and
pPKCε was ﬂowed over the sensor surface with various concentra-
tions (50–400 nM). The KD value was found to be 10 nM indicating a
high afﬁnity binding between pPKCε and HMGA1 (Fig. 6B). Immuno-
blot of palmitate incubated cells demonstrated a shift of HMGA1
protein band along with its weak expression which implied HMGA1
phosphorylation and reduction respectively (Fig. 6C). Suppression of
HMGA1 gene expression was also witnessed by RT-PCR and its
prevention by cerulenin or triacsin C imply interplay of pPKCε.
(Fig. 6C). Phosphorylation of HMGA1 by pPKCε was detected by the
transfer of radiolabeled phosphate in cell free incubation indicating
that HMGA1 is a substrate of activated PKCε (Fig. 6D). In searching thebasis of reduced HMGA1 expression we found increased phosphor-
ylation of Sp1 but not in Jun and Fos (Fig. 7A) which was again
indicated by the transfer of radiolabeled phosphate from 32pPKCε to
Sp1 (Fig. 7B). Sp1 binding to HMGA1 promoter was signiﬁcantly
reduced in palmitate incubated cells, while it was prevented in cells
pretreated with εV1. Addition of anti-Sp1 antibody supershifted the
binding complex indicating that this band was constituted by Sp1
(Fig. 7C). These results suggest that the phosphorylation of Sp1 by
pPKCε inhibits its binding to HMGA1 promoter resulting reduction of
its gene expression. There are evidences that phosphorylation of Sp1
deactivates it and decrease it's binding to DNA. Results described so
far indicate that pPKCε is a key player in FA induced damage of insulin
signaling.
3.6. Defects in HMGA1 due to pPKCε abrogate IRβ expression
Since F-actin–pPKCε complex has greater ability for phospho-
transferase activity [27], it is expected both HMGA1 and Sp1
phosphorylation would take place more efﬁciently and that would
produce defects in HMGA1. To examine this, we performed chromatin
immunoprecipitation (ChIP) assay and observed a reduction of
HMGA1 binding to IRβ promoter in palmitate treated cells. This was
prevented by cerulenin, triacsin C, cytochalasin B and εV1 indicating
that phosphorylation followed by nuclear translocation of pPKCε is
involved in inhibiting HMGA1 binding to IRβ promoter (Fig. 8A).
Fig. 6. pPKCε nuclear translocation impairs HMGA1. (A) L6 myotubes incubated with palmitate (P) or myristate (M) without or with CytoB. Nuclear fraction was isolated and
immunoprecipitated with anti-HMGA1 antibody followed by probing with anti-pPKCε or anti-IgG antibody. (B) Pure His-HMGA1 protein was immobilized to the Ni2+ coated NTA
sensor chip and varied concentrations of pPKCε protein (50, 100, 200, 400 nM) was run over it to analyze the binding between them with the help of surface plasmon resonance
study. The interactions were monitored in real time via the changes in refractive index which was proportional to the changes in mass concentration at the sensor chip surface and
plotted as RU (Resonance unit) versus time. Binding afﬁnity between HMGA1 and pPKCε was determined from the level of binding at equilibrium as a function of sample
concentration and referred as equilibrium dissociation constant (KD) as depicted in the inset. (C) Analysis of HMGA1 protein and mRNA level in L6 myotubes incubated with
palmitate in the presence of Cerulenin or Triacsin C by immunoblot (upper panel) or RT-PCR (lower panel). (D) L6 myotubes were incubated with palmitate in the presence of
[γ32p]-ATP. On termination of incubation, palmitate induced 32pPKCε was puriﬁed from these cells through immunoafﬁnity chromatography using anti-pPKCε antibody coupled
CNBr activated sepharose 4B column. 32pPKCε was incubated with HMGA1 protein for 30 min at 37 °C in cell free condition, HMGA1 was pulled down with anti-HMGA1 antibody
followed by SDS-PAGE and autoradiographed. PVDF membrane corresponding to the radioactive spots was cut and radiolabeled phosphate incorporated into HMGA1 was measured
in a liquid scintillation counter. Data were means±SEM of three individual observations, *pb0.001; vs HMGA1.
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reporter assay demonstrated a signiﬁcant decrease in luciferase
activity due to palmitate incubation. Attenuation of IRβ promoter
activity could also be prevented by cerulenin, triacsin C, cytoB and
εV1, suggesting once again the association of pPKCε in decreasing IRβ
promoter activity (Fig. 8B). All these suggest a deleterious effect of
pPKCε on IRβ expression.3.7. pPKCε mediated IRβ downregulation impairs insulin sensitivity
To examine whether palmitate-pPKCε-HMGA1 mediated reduction
of IRβ expression could reduce insulin sensitivity, we investigated GFP-
Glut4 migration to cell membrane and [3H]-2DOG uptake by L6
myotubes as these two are important markers for insulin action. In
GFP-Glut4 plasmid transfected L6 myotubes, insulin effected Glut4
migration from cytosol tomembranewas prevented by palmitate while
in cells cotransfected with mutated PKCε vector, where serine 729 was
replaced by alanine, palmitate did not inhibit insulin stimulated Glut4
migration (Fig. 9A). This was further evident from [3H]-2DOG uptakestudy in L6 myotubes (Fig. 9B). These ﬁndings demonstrate that FA's
damage to insulin sensitivity is mediated through PKCε.
4. Discussion
Binding of insulin to IR initiates insulin signaling in classical
insulin target cells. Several authors have demonstrated an associa-
tion between FAs and decreased IR in insulin target tissues and cells.
These defects in IR impair insulin signaling that compromises insulin
sensitivity and insulin resistance [1–13,15]. Such a large number of
citations favoring the issue that deﬁciency of IR is related to insulin
signaling defect raises a question about the spare receptor in target
cells. Concept of spare receptor in insulin target cells does not hold
good any more, insulin occupation of all high afﬁnity receptor
binding sites is required to ensure full receptor kinase activation thus
void the possibility of spare receptor in skeletal muscle [32,33] and
hepatocytes [34]. Since one high afﬁnity IR is for one molecule of
insulin [35], detection of absence of spare receptor is meaningful.
Evidences available with adipocytes suggest that spare receptor
phenomenon is due to post receptor event [32,36]. The reason for
Fig. 7. Reduction of HMGA1 gene expression by pPKCε. (A) Immunoblot analysis of phosphorylated Sp1, Jun and Fos level in L6 myotubes incubated without or with palmitate (P) in
absence or presence of εV1. (B) Radiolabeled 32pPKCε prepared according to the above description was incubated for 30 min at 30 °C with Sp1 followed by subjected to
autoradiography. PVDF membrane corresponding to the radioactive spot was cut and incorporation of radiolabeled phosphate to Sp1 was measured in a liquid scintillation counter.
Data represents means±SEM of three individual experiments, *pb0.01 vs Sp1. (C) Nuclear extracts isolated from control, palmitate or palmitate plus εV1 incubated L6 myotubes
were subjected to electrophoretic mobility shift assay (EMSA). Probing with anti-Sp1 antibody showed a shift of the band which indicates speciﬁc binding of Sp1 on the HMGA1
promoter.
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number of above mentioned reports which demonstrated associa-
tion of FA with IR reduction and found that this deﬁciency leads to
insulin signaling defects which affects insulin sensitivity [4,10–
13,15]. We have observed that in obese type 2 diabetic db/db miceFig. 8. pPKCε induced defects on HMGA1 attenuates IRβ promoter activity. (A) L6 myotubes
CytoB or εV1. On termination of the incubations, chromatin immunoprecipitation assay (Ch
region using anti-HMGA1 antibody. The recovered DNA was used as a template for PCR a
expressing plasmid was transfected into L6 myotubes followed by the same regime of incuba
in a luminometer. Data represents means±SEM of ﬁve individual experiments, *pb0.001 vabout 85–90% of IRβ has been degraded in skeletal muscle with
almost equal amount of reduction in its gene expression and this has
strikingly reduced insulin sensitivity. Hence, FA induced degradation
of IR would likely implement insulin resistance, a hall mark of type 2
diabetes.were incubated without or with palmitate in the presence of cerulenin or triacsin C or
IP) was performed with cell lysate by immunoprecipitating HMGA1 bound IR promoter
nalysis with primers of IRβ promoter. (B) IR promoter (pIRP-GLuc) driven luciferase-
tion as indicated above. On termination of incubation, luciferase activity was measured
s C, #pb0.01 vs P.
Fig. 9. Palmitate induced insulin signaling defects was prevented by kinase dead PKCε. (A) GFP-Glut4 vector transfected L6 myotubes were cotransfected with wild or PKCεmutant
vector (PKCε-S729A) followed by incubation with insulin (Ins) in the absence or presence of palmitate (P). GFP-Glut4 localization was detected by using Leica laser scanning confocal
microscope. (B) Cells from the same incubations with presence of [3H]-2DOG were lysed and counted in a liquid scintillation counter according to the procedure described in the
materials and method section. Data represent means±SEM of ﬁve individual experiments, *pb0.001 vs C, #pb0.01 vs Ins.
505S. Dasgupta et al. / Biochimica et Biophysica Acta 1812 (2011) 495–506Loss of insulin sensitivity due to FA induced defects in IR signaling
pathway is known for a long time. There are reports on the disruption
of every molecules of insulin signaling pathway due to FAs [37–39].
However, defects of any of them would adversely affect insulin
sensitivity. This makes our understanding a little cloudy although
there is no confusion that it is FAs which produces this defect as drug
induced decrease of circulatory FAs improves insulin sensitivity [40].
About a decade ago Ikeda et al. [13], taking a well characterized
diabetic animal model i.e., sand rat (Psammomys obesus) demonstrat-
ed that PKCε overexpression and activation has a link with decreased
IR expression and that impaired insulin downstream signaling. In fact,
there are several reports on PKCε involvement in insulin resistance
and type 2 diabetes [4,14,41] on one hand and loss of insulin
sensitivity due to FA induced IR degradation on the other [4,10,11] but
a link between them remains unclear. Present investigation has
contributed to make this understanding clear. We have shown that
target of FAs is PKCε, it begins disruption of insulin signals by
phosphorylating PKCε in a PDK1 independent pathway. Saturated
fatty acids, palmitate and myristate phosphorylated PKCε, an
unsaturated fatty acid, oleate also exhibited this property but it has
no inhibitory effect on IR expression. However, oleate adverse effect
on insulin sensitivity could be due to serine/threonine phosphoryla-
tion of IRS1 as reported by Ragheb et al. [42]. Once phosphorylated,
pPKCεmoves to the nuclear region. It was surprising to detect it there
as PKCε lacks NLS. We then understand the purpose of FA induced
phosphorylation of PKCε and why it is localized in the nuclear region
as a complex with F-actin. F-actin which has 13 NLS and it recognizes
only phospho-form of PKCε because phosphorylation exposes
hexapeptide F-actin binding motif at regulatory domain of PKCε.
This permits F-actin binding and transport of pPKCε to the nuclearregion [27,29]. In the nuclear region, pPKCε plays a key role, it
phosphorylates HMGA1 and downregulates its expression by deacti-
vating its transcription factor Sp1. Phosphorylation of HMGA1 by PKCs
has been amply reported earlier and this restricted its mobility
[43,44]. Phosphorylated HMGA1 preferentially interacts with posi-
tively charged histone that effected increase of its residence time in
heterochromatin region [45]. Regulation of HMGA1 expression is
dependent on the cooperation between Sp1 and AP1 transcription
factors [46] and phosphorylation of Sp1 has been shown to inhibit its
DNA binding activity [47]. These together attenuated IR gene and
protein expression which seriously compromised insulin sensitivity.
Novelty of our work lies in deciphering the underlying mechanism on
FA induced IRβ downregulation, the central regulator is phospho-
PKCε which forms connection between them and disrupt insulin
signaling by impairing HMGA1. We have demonstrated that through
this pathway FA caused insulin resistance in classical target cells.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbadis.2011.01.001.
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